Employers once again face a rather expensive healthcare conundrum. The prevalence of so called “GLP-1 drugs”, prescribed ostensibly for weight loss, is causing many to question the cost versus benefit aspect of these drugs. GLP-1 drugs are showing promise at delivering on the goal of weight loss, but they have not been around long enough to evaluate their long term side effects. And while demand for these drugs is definitely on the rise, they come at a very high price point.
